South & Central America Embolization Devices Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

Description

List of Tables

The embolization devices market in South and Central America is projected to grow significantly, reaching approximately US$ 352.84 million by 2031, up from US$ 192.82 million in 2024. This growth represents a compound annual growth rate (CAGR) of 9.1% from 2025 to 2031.

Executive Summary and Market Analysis

The market is divided into key regions: Brazil, Argentina, and the Rest of South and Central America. The region is poised for growth due to an increase in various health conditions, advancements in healthcare systems, and heightened awareness of chronic diseases. Additionally, the rise in unhealthy lifestyle choices among the population is leading to a greater incidence of diseases, thereby increasing the demand for embolization devices. Government initiatives aimed at improving healthcare are also expected to propel market growth. The aging population and rising healthcare expenditures further contribute to the demand for advanced medical treatments. Countries like Brazil and Mexico are enhancing their healthcare infrastructure and attracting foreign investments, which facilitates the adoption of innovative medical technologies.

Market Segmentation Analysis

The South and Central America embolization devices market is categorized by type, application, and end user.

By Type: The market includes embolization coils, plugs, beads, glues, and other devices. In 2024, embolization coils dominated the market share, with further segmentation into central and peripheral applications.
By Application: The market is segmented into neurology, peripheral vascular disease, oncology, urology, and others, with neurology holding the largest market share in 2024.
By End User: The end users are classified into hospitals, ambulatory centers, and others, with hospitals accounting for the largest share in 2024.

Market Outlook

Innovations in embolization devices, such as enhanced catheter designs, new embolic agents, and detachable coils, have improved the safety and effectiveness of embolization procedures. For instance, flow-diverting devices have transformed the treatment of complex intracranial aneurysms by redirecting blood flow away from the aneurysm, promoting thrombosis within the sac. Clinical studies play a crucial role in advancing these techniques, leading to broader applications and better patient outcomes. The IMPASS embolic coil device, developed by Fluidx Medical Technology, has shown promise in treating chronic subdural hematomas by targeting the middle meningeal artery, as evidenced by recent in-vivo studies.

The Caterpillar Arterial Embolization System, assessed in a first-in-human study, demonstrated successful occlusion in peripheral arteries with minimal risk of serious adverse events. This device, featuring opposing nitinol fibers and a flow-occluding membrane, aims to simplify the embolization process across various vessel sizes.

As the market evolves, the collaboration between clinical research and device innovation will be essential in meeting the increasing demand for effective embolization therapies. Integrating clinical studies into the development of these devices is becoming a significant trend, leading to advancements in treatment options and improved patient outcomes.

Country Insights

The South and Central America embolization devices market includes Brazil, Argentina, and other regions, with Brazil holding the largest market share in 2024. Trauma is a leading cause of death in Brazil, particularly among individuals aged 1-39, with embolization procedures being critical for controlling bleeding from injuries. The prevalence of abdominal aortic aneurysms, especially in individuals over 60, further underscores the importance of these procedures. The aging population in Brazil is expected to grow significantly, with projections indicating that by 2031, nearly 50 million people will be aged 60 and above, representing 24% of the population. This demographic shift highlights the increasing relevance of embolization procedures, which are favored for their minimally invasive nature and shorter recovery times compared to traditional surgeries.

Company Profiles

Key players in the embolization devices market include Medtronic Plc, Cook Medical Holdings LLC, Stryker Corp, Boston Scientific Corp, Terumo Corp, Johnson & Johnson, Abbott Laboratories, and others. These companies are pursuing strategies such as market expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase market share.

Product Code: BMIRE00032150

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
3.3 Assumptions and Limitations

4. South & Central America Embolization Devices Market - Key Market Dynamics

4.1 South & Central America Embolization Devices Market - Key Market Dynamics
4.2 Market Drivers
- 4.2.1 Rising Prevalence of Clinical Conditions
- 4.2.2 Burgeoning Demand for Minimally Invasive Techniques
4.3 Market Restraints
- 4.3.1 Complications Arising During or After Embolization
4.4 Market Opportunities
- 4.4.1 New Product Developments and Marketing Approvals
4.5 Future Trends
- 4.5.1 Transforming Embolization Through Clinical Innovation
4.6 Impact of Drivers and Restraints:

5. Embolization Devices Market - South & Central America Analysis

5.1 South & Central America Embolization Devices Market Revenue (US$ Million), 2021-2031
5.2 South & Central America Embolization Devices Market Forecast Analysis

6. South & Central America Embolization Devices Market Analysis - by Product Type

6.1 Embolization Coils
- 6.1.1 Overview
- 6.1.2 Embolization Coils: South & Central America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.2 Plugs
- 6.2.1 Overview
- 6.2.2 Plugs: South & Central America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.3 Beads
- 6.3.1 Overview
- 6.3.2 Beads: South & Central America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.4 Glues
- 6.4.1 Overview
- 6.4.2 Glues: South & Central America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.5 Others
- 6.5.1 Overview
- 6.5.2 Others: South & Central America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

7. South & Central America Embolization Devices Market Analysis - by Application

7.1 Neurology
- 7.1.1 Overview
- 7.1.2 Neurology: South & Central America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Peripheral Vascular Disease
- 7.2.1 Overview
- 7.2.2 Peripheral Vascular Disease: South & Central America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Oncology
- 7.3.1 Overview
- 7.3.2 Oncology: South & Central America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Urology
- 7.4.1 Overview
- 7.4.2 Urology: South & Central America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Others
- 7.5.1 Overview
- 7.5.2 Others: South & Central America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. South & Central America Embolization Devices Market Analysis - by End User

8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Hospitals: South & Central America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Ambulatory Centers
- 8.2.1 Overview
- 8.2.2 Ambulatory Centers: South & Central America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Others
- 8.3.1 Overview
- 8.3.2 Others: South & Central America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. South & Central America Embolization Devices Market - Country Analysis

9.1 South & Central America
- 9.1.1 South & Central America Embolization Devices Market - Revenue and Forecast Analysis - by Country
  - 9.1.1.1 South & Central America Embolization Devices Market - Revenue and Forecast Analysis - by Country
  - 9.1.1.2 Brazil: South & Central America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.1.1.2.1 Brazil: South & Central America Embolization Devices Market Share - by Product Type
    - 9.1.1.2.2 Brazil: South & Central America Embolization Devices Market Share - by Embolization Coils
    - 9.1.1.2.3 Brazil: South & Central America Embolization Devices Market Share - by Application
    - 9.1.1.2.4 Brazil: South & Central America Embolization Devices Market Share - by End User
  - 9.1.1.3 Argentina: South & Central America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.1.1.3.1 Argentina: South & Central America Embolization Devices Market Share - by Product Type
    - 9.1.1.3.2 Argentina: South & Central America Embolization Devices Market Share - by Embolization Coils
    - 9.1.1.3.3 Argentina: South & Central America Embolization Devices Market Share - by Application
    - 9.1.1.3.4 Argentina: South & Central America Embolization Devices Market Share - by End User
  - 9.1.1.4 Rest of South & Central America: South & Central America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.1.1.4.1 Rest of South & Central America: South & Central America Embolization Devices Market Share - by Product Type
    - 9.1.1.4.2 Rest of South & Central America: South & Central America Embolization Devices Market Share - by Embolization Coils
    - 9.1.1.4.3 Rest of South & Central America: South & Central America Embolization Devices Market Share - by Application
    - 9.1.1.4.4 Rest of South & Central America: South & Central America Embolization Devices Market Share - by End User

10. Competitive Landscape

10.1 Market Concentration by Key Players
10.2 Company Market Share Analysis, 2024

11. Industry Landscape

11.1 Overview
11.2 Expansion
11.3 New Product Development and Approval
11.4 Merger and Acquisition
11.5 Partnerships and Collaboration

12. Company Profiles

12.1 Medtronic Plc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Cook Medical Holdings LLC
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Stryker Corp
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Boston Scientific Corp
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Terumo Corp
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Johnson & Johnson
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Abbott Laboratories
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 NeuroSafe Medical Co. Ltd
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Wallaby Medical
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Sirtex Medical Ltd
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
12.11 GEM srl
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Products and Services
- 12.11.4 Financial Overview
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments
12.12 Penumbra Inc.
- 12.12.1 Key Facts
- 12.12.2 Business Description
- 12.12.3 Products and Services
- 12.12.4 Financial Overview
- 12.12.5 SWOT Analysis
- 12.12.6 Key Developments
12.13 Balt
- 12.13.1 Key Facts
- 12.13.2 Business Description
- 12.13.3 Products and Services
- 12.13.4 Financial Overview
- 12.13.5 SWOT Analysis
- 12.13.6 Key Developments
12.14 Lepu Medical Technology Beijing Co Ltd
- 12.14.1 Key Facts
- 12.14.2 Business Description
- 12.14.3 Products and Services
- 12.14.4 Financial Overview
- 12.14.5 SWOT Analysis
- 12.14.6 Key Developments
12.15 INVAMED
- 12.15.1 Key Facts
- 12.15.2 Business Description
- 12.15.3 Products and Services
- 12.15.4 Financial Overview
- 12.15.5 SWOT Analysis
- 12.15.6 Key Developments
12.16 Meril Life Sciences Pvt Ltd
- 12.16.1 Key Facts
- 12.16.2 Business Description
- 12.16.3 Products and Services
- 12.16.4 Financial Overview
- 12.16.5 SWOT Analysis
- 12.16.6 Key Developments
12.17 Merit Medical Systems Inc
- 12.17.1 Key Facts
- 12.17.2 Business Description
- 12.17.3 Products and Services
- 12.17.4 Financial Overview
- 12.17.5 SWOT Analysis
- 12.17.6 Key Developments
12.18 Lifetech Scientific Corp
- 12.18.1 Key Facts
- 12.18.2 Business Description
- 12.18.3 Products and Services
- 12.18.4 Financial Overview
- 12.18.5 SWOT Analysis
- 12.18.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms